Bivalirudin Trifluoroacetate CAS NO.128270-60-0
TECHNICAL SPECIFICATIONS
| Item | Specification |
|---|---|
| Product Name | Bivalirudin Trifluoroacetate |
| CAS NO. | 128270-60-0 |
| Appearance | White to off-white lyophilized powder |
| Molecular Formula | C98H138N24O33 |
| Molecular Weight | 2180.33 g/mol |
| Purity (RP-HPLC) | ≥ 98.0% |
| Solubility | Soluble in water; soluble in dilute acids and certain buffers (pH-dependent) |
| Endotoxin | < 0.05 EU/mg |
| Biological Activity | Potent direct thrombin inhibitor; inhibits thrombin-induced platelet aggregation and fibrin formation |
| Storage Conditions | Store at 2–8°C, protected from light and moisture |
| Stock Location | Stock in USA |
| MOQ | 1g |
1.MECHANISM OF ACTION
Bivalirudin Trifluoroacetate functions as a bivalent direct thrombin inhibitor by specifically and reversibly binding to both the catalytic site and the anion-binding exosite of thrombin. This dual binding mechanism effectively blocks thrombin's interaction with its substrates, inhibiting the conversion of fibrinogen to fibrin and preventing thrombus formation. Unlike indirect inhibitors like heparin, it acts independently of antithrombin III and can inhibit both circulating (free) and clot-bound thrombin, which is often inaccessible to other anticoagulants. This direct action results in a rapid and predictable dose-dependent anticoagulant effect, prolonging clotting times such as ACT and aPTT without causing heparin-induced thrombocytopenia.
2.PRODUCT INDICATIONS
This API is indicated for the formulation of anticoagulant drugs used in patients undergoing percutaneous coronary intervention (PCI), including those with unstable angina or acute coronary syndromes. A key population for this product is individuals with or at risk of heparin-induced thrombocytopenia (HIT) or HIT with thrombosis syndrome (HITTS), who require an effective alternative to heparin. It is also utilized in clinical settings where a short-acting, reversible anticoagulant is preferred to minimize bleeding risks, making it suitable for high-bleeding-risk patients and those requiring precise procedural anticoagulation control during cardiac catheterization and angioplasty.
3.CLINICAL EFFICACY OF PRODUCT
Clinical studies, including the large-scale REPLACE-2 trial, have demonstrated that bivalirudin-based regimens achieve non-inferior rates of ischemic protection (death, myocardial infarction, revascularization) compared to heparin plus glycoprotein IIb/IIIa inhibitors in PCI patients. Its primary clinical advantage lies in a significantly reduced risk of major bleeding complications. In patients with ST-segment elevation myocardial infarction (STEMI) and non-ST-elevation acute coronary syndromes (NSTE-ACS), bivalirudin has been associated with lower mortality and net adverse clinical events, offering a superior safety profile, especially in populations where bleeding risk is a major concern.
4.Certificate
GlobalTech Co., Ltd. is committed to providing high-purity biotechnological peptide products, adhering strictly to quality standards and obtaining internationally recognized certifications.
Our production partners all employ GMP-compliant production systems and possess standardized quality control processes covering raw material procurement, synthesis, purification, testing, packaging, and storage. Each batch of product comes with complete documentation, including a Certificate of Analysis (COA), HPLC purity report, mass spectrometry (MS) chromatograms, and third-party testing reports available upon request.
We prioritize:
1.A rigorous quality management system
2.Batch traceability and stability data
3.Professional laboratory testing and validation
4.Compliance with international trade standards
Our commitment to quality, transparency, and regulatory compliance ensures the provision of reliable, stable, and research-grade peptide products to our global partners.
5.DELIVERY & SHIPPING
We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods
Main Method: International Air Freight
We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.
Global Technology Co., Ltd. is a modern and advanced enterprise specializing in the production and export of active pharmaceutical ingredients (APIs), peptides, and plant extracts. The company invests in and collaborates closely with domestic manufacturers holding GMP, DMF, and FDA certifications, as well as laboratories at renowned universities, to meet diverse customer needs ranging from gram-level to ton-level. This enables Dejurui Pharmaceutical to provide customers with more flexible and convenient access to cost-effective, high-quality products and superior services.
We focus on the research and development and supply of high-quality chemical products, strictly adhering to international standards and quality systems. Our products are stable in performance and reliable in purity, widely used in industrial manufacturing, scientific research, and the fine chemical industry. We provide solid support at every stage with a professional and responsible attitude.
Hot Tags:Bivalirudin, BivalirudinTrifluoroacetate, BivalirudinTFA, Anticoagulant, ThrombinInhibitor, PeptideAPI, PCI, HIT, Cardiology, PharmaceuticalIntermediate, APIs, Hirulog, Angiomax, Supplier, Manufacturer, Bulk order, Pharmaceutical.
If you have any product requirements, please send an email to:business@huanqiukeji9.com;whatsapp:85270846510
